Literature DB >> 21878844

Determination of retinal and vitreous temperature in vitrectomy.

Maurice B Landers1, Jessica S Watson, J Niklas Ulrich, Hugo Quiroz-Mercado.   

Abstract

PURPOSE/
BACKGROUND: To maximize recovery after neurologic injury, physicians use therapeutic hypothermia of 90°F to 93°F (32.2-33.9°C). Temperatures below this are avoided because of increased side effects. The extent to which the retina is cooled during routine vitreous surgery is unknown. This study seeks to describe the temperature changes of the vitreous and retinal surface during vitreous surgery.
METHODS: In this prospective study of 6 patients undergoing vitrectomy, a 23-gauge thermoprobe was used to measure intraocular temperatures before, during, and after vitrectomy.
RESULTS: Before vitrectomy, the mean midvitreous temperature was 93.1°F (33.9°C) and retinal temperature was 94.7°F to 95.4°F (34.8-35.2°C). During vitrectomy, the mean midvitreous cavity temperature was 76.9°F (24.9°C) and retinal temperature was 83.2°F to 85.1°F (28.4-29.5°C). After completion of vitrectomy and with a closed infusion line, the mean midvitreous cavity temperature was 87.0°F (30.6°C) and retinal temperature was 90.1°F to 90.9°F (32.3-32.7°C). These changes in temperature before, during, and after vitrectomy were found to be statistically significant.
CONCLUSION: During routine vitreous surgery, the vitreous cavity and retina are cooled to much lower temperatures than those used in therapeutic hypothermia. Rapid rewarming occurs within the eye once the infusion line is closed.

Entities:  

Mesh:

Year:  2012        PMID: 21878844     DOI: 10.1097/IAE.0b013e31821c3ee0

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  8 in total

1.  Preventing condensation of objective lens in noncontact wide-angle viewing systems during vitrectomy.

Authors:  Jung Pil Lee; Jinsoo Kim; Inwon Park; Ho Ra; Soonil Kwon
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

2.  The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery.

Authors:  Shrirang V Ranade; Mark R Wieland; Tammy Tam; Jennifer C Rea; Judit Horvath; Aaron R Hieb; Weitao Jia; Lori Grace; Giulio Barteselli; Jay M Stewart
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

3.  Vitreous humor thermodynamics during phacoemulsification.

Authors:  Guillermo Salcedo-Villanueva; Veronica Kon-Jara; Mariana Harasawa; Guadalupe Cervantes-Coste; Daniel Ochoa-Contreras; Virgilio Morales-Cantón; José Luis Guerrero-Naranjo; Hugo Quiroz-Mercado; Maurice B Landers
Journal:  Int Ophthalmol       Date:  2014-08-07       Impact factor: 2.031

4.  Intraoperative Electroretinograms before and after Core Vitrectomy.

Authors:  Kazuma Yagura; Kei Shinoda; Soiti Matsumoto; Gaku Terauchi; Emiko Watanabe; Harue Matsumoto; Goichi Akiyama; Atsushi Mizota; Yozo Miyake
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

5.  The Effect of Temperature Changes in Vitreoretinal Surgery.

Authors:  Mario R Romano; Vito Romano; Alessandro Mauro; Martina Angi; Ciro Costagliola; Luigi Ambrosone
Journal:  Transl Vis Sci Technol       Date:  2016-02-09       Impact factor: 3.283

6.  Intraocular Temperature Distribution in Eyes Undergoing Different Types of Surgical Procedures during Vitreous Surgery.

Authors:  Kei Shinoda; Soiti C Matsumoto; Kazuma Yagura; Gaku Terauchi; Takuhei Shoji; Yuji Yoshikawa; Yuro Igawa; Atsushi Mizota; Yozo Miyake
Journal:  J Clin Med       Date:  2022-04-06       Impact factor: 4.241

7.  Decreased VEGF-A and sustained PEDF expression in a human retinal pigment epithelium cell line cultured under hypothermia.

Authors:  Masayuki Takeyama; Masahiko Yoneda; Masahiko Gosho; Masayoshi Iwaki; Masahiro Zako
Journal:  Biol Res       Date:  2015-07-30       Impact factor: 5.612

8.  Expression of VEGF-A, Otx homeobox and p53 family genes in proliferative vitreoretinopathy.

Authors:  Claudio Azzolini; Ilaria Stefania Pagani; Cristina Pirrone; Davide Borroni; Simone Donati; Muna Al Oum; Diana Pigni; Anna Maria Chiaravalli; Riccardo Vinciguerra; Francesca Simonelli; Giovanni Porta
Journal:  Mediators Inflamm       Date:  2013-10-21       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.